Literature DB >> 6607889

Susceptibility and tolerance of beta-lactamase-producing, methicillin-sensitive strains of Staphylococcus aureus towards seven broad-spectrum penicillins.

R Wehrli, A von Graevenitz, R Lüthy.   

Abstract

The activity of penicillin G, ampicillin, carbenicillin, ticarcillin, azlocillin, mezlocillin and piperacillin against 102 beta-lactamase-producing, methicillin-sensitive strains of Staphylococcus aureus was determined by agar dilution (method A) and broth microdilution (method B) techniques. By NCCLS breakpoint criteria, 4% of the strains were "sensitive" to penicillin and ampicillin, and almost 100% were "sensitive" to the other drugs when method A was used. Results with method B were only significantly lower as far as the cumulative percentage of strains "sensitive" to azlocillin, mezlocillin and piperacillin was concerned (63-71%). Bactericidal effects at "sensitive" levels were observed in 0-2% (penicillin, ampicillin), 31-35% (carbenicillin, ticarcillin) and 10-14% (azlocillin, mezlocillin, piperacillin). While differences in MIC and MBC levels ranged from 0 to 8 dilution steps, tolerance (a greater than 32-fold difference) was seen in at least 9-22% of all strains (depending on the drug tested); experimental limitations, however, excluded a determination of tolerance in all our strains. In a semi-quantitative nitrocefin assay, "strong" beta-lactamase production was correlated to high MIC and/or MBC levels.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6607889     DOI: 10.1007/bf01641357

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  15 in total

1.  Agar disk diffusion susceptibility characteristics of azlocillin, carbenicillin, mezlocillin, piperacillin, and ticarcillin.

Authors:  D Phaneuf; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

2.  The penicillins.

Authors:  C J Wilkowske
Journal:  Mayo Clin Proc       Date:  1977-10       Impact factor: 7.616

3.  Laboratory determination of antibiotic susceptibility to ampicillin and cephalothin.

Authors:  J C Sherris; A L Rashad; G A Lighthart
Journal:  Ann N Y Acad Sci       Date:  1967-09-27       Impact factor: 5.691

4.  Variables in demonstrating methicillin tolerance in Staphylococcus aureus strains.

Authors:  K Ishida; P A Guze; G M Kalmanson; K Albrandt; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

5.  In vitro activity of carbenicillin, ticarcillin, aminoglycosides and combinations against Staphylococcus aureus.

Authors:  C Watanakunakorn; C Glotzbecker
Journal:  J Antimicrob Chemother       Date:  1979-03       Impact factor: 5.790

6.  In vitro and in vivo studies of three antibiotic combinations against gram-negative bacteria and Staphylococcus aureus.

Authors:  S H Zinner; J Klastersky; H Gaya; C Bernard; J C Ryff
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

7.  Comparative activity in vitro of ticarcillin, BL-P1654, and carbenicillin.

Authors:  T C Eickhoff; J M Ehret
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

8.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

9.  A new type of penicillin resistance of Staphylococcus aureus.

Authors:  L D Sabath; N Wheeler; M Laverdiere; D Blazevic; B J Wilkinson
Journal:  Lancet       Date:  1977-02-26       Impact factor: 79.321

Review 10.  Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.

Authors:  G M Eliopoulos; R C Moellering
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

View more
  1 in total

1.  Resignment: Infection is grateful to Prof. Alexander von Graevenitz.

Authors:  Johannes R Bogner
Journal:  Infection       Date:  2018-12       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.